This analysis also revealed that the expression of low AnxA6/high GRF2 and high Ki67 is associated with poorer RFS of basal-like breast cancer patients compared to those expressing high AnxA6/low GRF2 and low Ki67 (S4 Fig). Here, ANXA6 is linked to breast carcinoma.